{"transactions":[{"id":673763,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":19081,"kind":"person","name":"Anderson Woodrow D","position":1,"cik":"0002014440","reported_name":"Anderson Woodrow D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-08-27T20:00:46.000Z","date":"2026-08-27","kind":"purchase","planned":false,"acquired":true,"shares":1500,"price":35.69,"value":53535.0,"ownership":{"direct":true},"balance_after":27638,"source":{"system":"sec-edgar","filing":"0002014440-26-000012","document":"wk-form4_1787860844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201444026000012/wk-form4_1787860844.xml","form_type":"4"}},{"id":695684,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":19081,"kind":"person","name":"Anderson Woodrow D","position":1,"cik":"0002014440","reported_name":"Anderson Woodrow D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-08-05T20:52:07.000Z","date":"2026-08-05","kind":"purchase","planned":false,"acquired":true,"shares":1500,"price":36.28,"value":54420.0,"ownership":{"direct":true},"balance_after":26138,"source":{"system":"sec-edgar","filing":"0002014440-26-000010","document":"wk-form4_1785963124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201444026000010/wk-form4_1785963124.xml","form_type":"4"}},{"id":858306,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":19081,"kind":"person","name":"Anderson Woodrow D","position":1,"cik":"0002014440","reported_name":"Anderson Woodrow D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:00:48.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":5946,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit and restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit and restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This award is fully vested in accordance with its terms, effective March 3, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This award is fully vested in accordance with its terms, effective March 3, 2026."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2026-03-03","underlying":"Common Stock","underlying_shares":5946},"source":{"system":"sec-edgar","filing":"0002014440-26-000007","document":"wk-form4_1772744446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201444026000007/wk-form4_1772744446.xml","form_type":"4"}},{"id":858305,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":19081,"kind":"person","name":"Anderson Woodrow D","position":1,"cik":"0002014440","reported_name":"Anderson Woodrow D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Performance Stock Units","published_at":"2026-03-05T21:00:48.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":23975,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit and restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit and restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 18,364 shares vested out of the 23,975 target amount."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 18,364 shares vested out of the 23,975 target amount."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2026-03-03","underlying":"Common Stock","underlying_shares":23975},"source":{"system":"sec-edgar","filing":"0002014440-26-000007","document":"wk-form4_1772744446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201444026000007/wk-form4_1772744446.xml","form_type":"4"}},{"id":858304,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":19081,"kind":"person","name":"Anderson Woodrow D","position":1,"cik":"0002014440","reported_name":"Anderson Woodrow D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:00:48.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":2682,"price":31.98,"value":85770.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares used to satisfy tax withholding obligations associated with the vesting of restricted stock units on March 3, 2026."}],"balance_after":24638,"source":{"system":"sec-edgar","filing":"0002014440-26-000007","document":"wk-form4_1772744446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201444026000007/wk-form4_1772744446.xml","form_type":"4"}},{"id":858303,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":19081,"kind":"person","name":"Anderson Woodrow D","position":1,"cik":"0002014440","reported_name":"Anderson Woodrow D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:00:48.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":5946,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit and restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":27320,"source":{"system":"sec-edgar","filing":"0002014440-26-000007","document":"wk-form4_1772744446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201444026000007/wk-form4_1772744446.xml","form_type":"4"}},{"id":858302,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":19081,"kind":"person","name":"Anderson Woodrow D","position":1,"cik":"0002014440","reported_name":"Anderson Woodrow D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:00:48.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":8283,"price":31.98,"value":264890.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares used to satisfy tax withholding obligations associated with the vesting of performance stock units on March 3, 2026."}],"balance_after":21374,"source":{"system":"sec-edgar","filing":"0002014440-26-000007","document":"wk-form4_1772744446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201444026000007/wk-form4_1772744446.xml","form_type":"4"}},{"id":858301,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":19081,"kind":"person","name":"Anderson Woodrow D","position":1,"cik":"0002014440","reported_name":"Anderson Woodrow D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:00:48.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":18364,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 18,364 shares vested out of the 23,975 target amount."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit and restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":29657,"source":{"system":"sec-edgar","filing":"0002014440-26-000007","document":"wk-form4_1772744446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201444026000007/wk-form4_1772744446.xml","form_type":"4"}},{"id":907558,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":19081,"kind":"person","name":"Anderson Woodrow D","position":1,"cik":"0002014440","reported_name":"Anderson Woodrow D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-12T21:08:22.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":23975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 3, 2023, the Reporting Person was granted a conditional award for 23,975 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 3, 2023, the Reporting Person was granted a conditional award for 23,975 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026."}],"balance_after":23975,"derivative":{"exercise_price":0,"exercise_date":"2026-03-03","underlying":"Common Stock","underlying_shares":23975},"source":{"system":"sec-edgar","filing":"0002014440-26-000005","document":"wk-form4_1770930497.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201444026000005/wk-form4_1770930497.xml","form_type":"4"}},{"id":907557,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":19081,"kind":"person","name":"Anderson Woodrow D","position":1,"cik":"0002014440","reported_name":"Anderson Woodrow D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:08:22.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":6903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on\nFebruary 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":11293,"source":{"system":"sec-edgar","filing":"0002014440-26-000005","document":"wk-form4_1770930497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201444026000005/wk-form4_1770930497.xml","form_type":"4"}}]}